INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Evolving irt]( "Evolving IRT For Today's Trials: Flexibility, Site Experience, And Integrated Workflow")
Evolving IRT For Today's Trials: Flexibility, Site Experience, And Integrated WorkflowInteractive Response Technology is evolving beyond traditional randomization and trial supply management to help guide protocol workflows in increasingly complex studies.
-
![GettyImages-953782406-digital-patients-people-recruit]( "Transforming Effective Patient Recruitment Within The Changing Health Care Landscape")
Transforming Effective Patient Recruitment Within The Changing Health Care LandscapeRevolutionize patient enrollment by closing the "95% gap." Explore an approach that uses digital health and data-driven insights to engage diverse populations where they live.
-
![retinal-studies-GettyImages-1425487363]( "Eligibility Criteria For Successful Retinal Study Delivery")
Eligibility Criteria For Successful Retinal Study DeliveryClear eligibility criteria drive retinal trial success. Explore how strategic design improves recruitment, safeguards data integrity, and meets compliance for studies on complex ocular conditions.
-
![GettyImages-1257716223 fda guide]( "The Final DCT Guidance: I'm Not Mad At It")
The Final DCT Guidance: I'm Not Mad At ItExplore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.
-
Unlocking The Potential of RWD In Clinical Trial Recruitment4/25/2025
Insights derived from real-world data can be used not only to identify potential patients for participation in clinical research, but also to inform the overall patient engagement and retention strategy of a clinical trial.
-
Navigating The Complexities Of Cross-Border Clinical Trials4/28/2025
Explore the regulatory, logistical, and patient-centered challenges of cross-border clinical trials, including insights on enhancing collaboration and prioritizing patients in global research.
-
From Weeks To Days: An Innovative Approach To Patient Recruitment10/28/2025
Discover how AI-driven, personalized communication can break linguistic and literacy barriers to make patient recruitment faster, more inclusive, and 30% more effective.
-
Human Abuse Potential: Selecting A Positive Control5/8/2026
Choosing an effective positive control in HAP studies is critical but not always straightforward. Learn how to justify comparator and dose selection.
-
Elevating The Site Voice3/27/2025
A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1132766141 patient recruitment]( "A New Blueprint For Transforming Feasibility And Recruitment")
Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.
-
![GettyImages-1318863581 patient travel]( "Patient Travel And Logistics")
Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.
-
![GettyImages-165180340-digital-recruitment-people-patients]( "Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle")
Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
-
![GettyImages-1400967286 regulations computer]( "Mastering Multi-Channel, Multi-Vendor Clinical Trial Recruitment")
See how Citeline Connect is expanding sponsors’ reach to the right patients through a marketplace of 100+ recruitment vendors and a network of 1.7 million-plus healthcare professionals through a single platform.
-
![Clinical Trial Recruitment Reinvented]( "Clinical Trial Recruitment Reinvented")
Clinical Site Services (CSS) is the industry leader in delivering strategic patient recruitment and enrollment solutions to study sites, sponsors and CROs.
